IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Reuters
Nov 20
Nov 7 (Reuters) - IO Biotech Inc :: *IO BIOTECH PRESENTS PRE-CLINICAL DATA HIGHLIGHTING THE POTENTIAL OF ADDITIONAL THERAPEUTIC CANCER VACCINE CANDIDATES AT THE 2025 ANNUAL MEETING OF THE SOCIETY FOR IMMUNOTHERAPY OF CANCER $(SITC)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.